These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 9481035

  • 1. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J, Eyrolles L, Bruhwyler J, Delarge J.
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [Abstract] [Full Text] [Related]

  • 2. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.
    Sanyal S, Van Tol HH.
    J Psychiatr Res; 1997 Apr; 31(2):219-32. PubMed ID: 9278187
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM, Sanyal S, Van Tol HH.
    Eur J Pharmacol; 1998 Jun 26; 351(3):273-86. PubMed ID: 9721018
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
    Jardemark K, Wadenberg ML, Grillner P, Svensson TH.
    Curr Opin Investig Drugs; 2002 Jan 26; 3(1):101-5. PubMed ID: 12054059
    [Abstract] [Full Text] [Related]

  • 5. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb 26; 24(1):13-20. PubMed ID: 15027326
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D4 receptors and development of newer antipsychotic drugs.
    Kulkarni SK, Ninan I.
    Fundam Clin Pharmacol; 2000 Feb 26; 14(6):529-39. PubMed ID: 11206702
    [Abstract] [Full Text] [Related]

  • 7. The D2 receptor: love it and leave it.
    Pickar D.
    Mol Psychiatry; 1998 Mar 26; 3(2):101-2. PubMed ID: 9577830
    [No Abstract] [Full Text] [Related]

  • 8. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb 26; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 9. The importance of dopamine D4 receptors in the action and development of antipsychotic agents.
    Reynolds GP.
    Drugs; 1996 Jan 26; 51(1):7-11. PubMed ID: 8741229
    [Abstract] [Full Text] [Related]

  • 10. The discovery of potent and selective dopamine D4 receptor antagonists.
    Faraci WS, Zorn SH, Sanner MA, Fliri A.
    Curr Opin Chem Biol; 1998 Aug 26; 2(4):535-40. PubMed ID: 9736928
    [Abstract] [Full Text] [Related]

  • 11. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL, Mors NP, Rosenberg R.
    Ugeskr Laeger; 1996 Jun 17; 158(25):3601-3. PubMed ID: 8693618
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P.
    Neuropsychopharmacology; 1992 Dec 17; 7(4):261-84. PubMed ID: 1362057
    [Abstract] [Full Text] [Related]

  • 13. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS, Last B, Getson A, Reines SA.
    Arch Gen Psychiatry; 1997 Jun 17; 54(6):567-72. PubMed ID: 9193198
    [Abstract] [Full Text] [Related]

  • 14. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H, Ebdrup BH, Fagerlund B, Svarer C, Rasmussen H, Friberg L, Allerup PN, Rostrup E, Pinborg LH, Glenthøj BY.
    Int J Neuropsychopharmacol; 2016 May 17; 19(5):. PubMed ID: 26819282
    [Abstract] [Full Text] [Related]

  • 15. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S, Seeman P.
    Am J Psychiatry; 2001 Mar 17; 158(3):360-9. PubMed ID: 11229973
    [Abstract] [Full Text] [Related]

  • 16. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.
    Am J Psychiatry; 2004 Sep 17; 161(9):1620-5. PubMed ID: 15337652
    [Abstract] [Full Text] [Related]

  • 17. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN.
    Arch Gen Psychiatry; 1997 Mar 17; 54(3):225-32. PubMed ID: 9075463
    [Abstract] [Full Text] [Related]

  • 18. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G, Knowles MR, Ward-Booth SM, Sinclair HA, Patel S, Marwood R, Emms F, Patel S, Smith A, Seabrook GR.
    J Recept Signal Transduct Res; 1995 Mar 17; 15(1-4):267-81. PubMed ID: 8903944
    [Abstract] [Full Text] [Related]

  • 19. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun 17; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 20. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.
    Pugsley TA, Shih YH, Whetzel SZ, Zoski K, Van Leeuwen D, Akunne H, Mackenzie R, Heffner TG, Wustrow D, Wise LD.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb 17; 26(2):219-26. PubMed ID: 11817497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.